Literature DB >> 1772290

Absence of an association between HLA typing in cystic fibrosis arthritis and hypertrophic osteoarthropathy.

P J Rush1, D D Gladman, A Shore, K A Anhorn.   

Abstract

Fourteen patients with cystic fibrosis arthritis and eight patients with cystic fibrosis and hypertrophic osteoarthropathy were typed for HLA-A, B, C, DR, and DQ antigens and were compared with age and sex matched controls with cystic fibrosis. The diagnosis of cystic fibrosis arthritis and hypertrophic osteoarthropathy was confirmed by radiography and bone scanning. The prevalence of HLA-A, B, C, D, antigens in the cystic fibrosis group (44 patients) did not differ from that in the control group. A comparison between patients with cystic fibrosis arthritis or hypertrophic osteoarthropathy and their respective controls did not show any significant differences in HLA prevalence. It is concluded that HLA antigens may not be a factor in the susceptibility of patients with cystic fibrosis to cystic fibrosis arthritis or hypertrophic osteoarthropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1772290      PMCID: PMC1004553          DOI: 10.1136/ard.50.11.763

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  A search for linkage in cystic fibrosis.

Authors:  M C Goodchild; J H Edwards; K P Glenn; C Grindey; R Harris; P Mackintosh; J Wentzel
Journal:  J Med Genet       Date:  1976-12       Impact factor: 6.318

2.  HLA frequencies in patients with cystic fibrosis.

Authors:  J Säfwenberg; H Kollberg; J B Lindblom
Journal:  Tissue Antigens       Date:  1977-10

3.  Letter: Cystic fibrosis and HL-A antigens.

Authors:  Z Polymenidis; H Ludwig; M Götz
Journal:  Lancet       Date:  1973-12-22       Impact factor: 79.321

4.  Reiter's disease and HL-A 27.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; J K Oates; D C James
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

Review 5.  Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.

Authors:  P I Terasaki; D Bernoco; M S Park; G Ozturk; Y Iwaki
Journal:  Am J Clin Pathol       Date:  1978-02       Impact factor: 2.493

6.  Atopy and bronchial reactivity in older patients with cystic fibrosis.

Authors:  M J Tobin; O Maguire; D Reen; E Tempany; M X Fitzgerald
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

7.  Cystic fibrosis and HLA.

Authors:  A Hennequet; M Jehanne; H Betuel; R Gilly; M Schmid; J Hors
Journal:  Tissue Antigens       Date:  1978-09

8.  The arthropathy of cystic fibrosis.

Authors:  J Dixey; A N Redington; R C Butler; M J Smith; J R Batchelor; D F Woodrow; M E Hodson; J C Batten; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

9.  Cystic fibrosis: a HLA associated hereditary disease?

Authors:  G I Kaiser; A László; K Gyurkovits
Journal:  Acta Paediatr Acad Sci Hung       Date:  1977

10.  HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.

Authors:  D D Gladman; K A Anhorn
Journal:  J Rheumatol       Date:  1986-04       Impact factor: 4.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.